Envoy Medical Inc. (COCH)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $52.16M
Last updated: Nov 17, 2026 at 10:59 AM ET
Envoy Medical Inc. (COCH) Stock Forecast
Analysts expect Envoy Medical (COCH) to earn -$2.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $237000. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$2.44.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 15.3%.
- Fiscal year ending Dec 31, 2026
- -$2.62
- EPS consensus, revenue $237000
- Fiscal year ending Dec 31, 2027
- -$2.44
- EPS consensus, revenue $273330
- Next report
- Mar 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.62 | -$2.66 to -$2.60 | 3 | $237000 | $200000 to $300000 | 3 |
| Dec 31, 2027 | -$2.44 | -$2.70 to -$2.25 | 3 | $273330 | $200000 to $400000 | 3 |
Quarterly Estimates
The EPS consensus rises from -$0.71 for the quarter ending Dec 31, 2026 to -$0.61 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.71 | -$0.88 to -$0.63 | 5 | $88403 | $58800 to $105000 | 5 |
| Mar 31, 2027 | -$0.61 | -$0.66 to -$0.53 | 3 | $100000 | $100000 to $100000 | 3 |
Estimate Revisions
No EPS estimate for the 2 periods below was revised in the last 30 days.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$3.10.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.62 | -$2.87 | -$2.87 | -$2.95 | -$3.10 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.44 | -$2.35 | -$2.37 | -$2.20 | -$2.25 | N/A |
| Quarter ending Mar 31, 2027 | -$0.61 | -$0.65 | -$0.63 | -$0.65 | -$0.65 | N/A |
Frequently Asked Questions About COCH
What is the COCH stock forecast?
Consensus analyst estimates put Envoy Medical's EPS at -$2.62 for the fiscal year ending Dec 31, 2026, on revenue of $237000. The consensus rating from 3 analysts is Buy.
How do analysts rate COCH stock?
Of 3 analysts covering Envoy Medical, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from COCH next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.62, with estimates from -$2.66 to -$2.60 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.44, with estimates from -$2.70 to -$2.25 from 3 analysts.
What revenue do analysts expect from Envoy Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $237000, with estimates from $200000 to $300000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $273330, with estimates from $200000 to $400000.
How many analysts cover COCH?
3 analysts rate Envoy Medical stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
COCH pages: Overview, Earnings, Forecast, Financials, Competitors